Keyword Analysis & Research: karuna therapeutics
Keyword Research: People who searched karuna therapeutics also searched
Search Results related to karuna therapeutics on Search Engine
-
Home • Karuna
https://karunatx.com/
WEBKaruna is the Sanskrit word for action taken to diminish the suffering of others. We are dedicated to championing the needs and experiences of people living with mental illness as we work toward our mission of developing and delivering transformative medicines for …
DA: 56 PA: 15 MOZ Rank: 9
-
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics
https://news.bms.com/news/details/2024/Bristol-Myers-Squibb-Completes-Acquisition-of-Karuna-Therapeutics-Strengthening-Neuroscience-Portfolio/default.aspx
WEBMar 18, 2024 · Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio. KarXT, Karuna’s Lead Asset, Is a Potential First-in-Class Treatment for Schizophrenia with Multi-Billion Dollar Sales Potential Across Multiple Indications. PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: …
DA: 14 PA: 52 MOZ Rank: 58
-
About Us • Karuna
https://karunatx.com/about-us/
WEBWe are a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. We pride ourselves on our deep expertise in neuroscience and inventive thinking around drug discovery and development.
DA: 20 PA: 60 MOZ Rank: 76
-
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
https://www.nytimes.com/2023/12/22/business/bristol-myers-karuna-drug-deal.html
WEBDec. 22, 2023. Bristol Myers Squibb, the global pharmaceutical giant, said on Friday that it would acquire Karuna Therapeutics, which makes drugs to treat schizophrenia and Alzheimer’s, in an...
DA: 4 PA: 61 MOZ Rank: 61
-
Pipeline & Programs • Karuna
https://karunatx.com/pipeline-programs/
WEBDiscover Karuna; Our Focus. Schizophrenia; Psychosis in Alzheimer’s Disease; Pipeline & Programs. Pipeline; KarXT; Clinical Trials; Partnerships & Collaborations; Research; Patient Resources. Approach; Advocacy; Resources; Culture & Careers. Benefits; Open Positions
DA: 70 PA: 91 MOZ Rank: 68
-
Karuna Therapeutics Submits New Drug Application to U.S. Food …
https://investors.karunatx.com/news-releases/news-release-details/karuna-therapeutics-submits-new-drug-application-us-food-and
WEBSep 28, 2023 at 6:30 AM EDT. PDF Version. KarXT, a dual M1/M4 muscarinic agonist, represents the first new mechanism of action to treat schizophrenia in several decades, if approved. Submission is supported by data from three positive registrational trials demonstrating consistent and robust reductions of schizophrenia symptoms.
DA: 46 PA: 57 MOZ Rank: 68
-
Karuna Therapeutics Announces Positive Results from Phase 3 …
https://investors.karunatx.com/news-releases/news-release-details/karuna-therapeutics-announces-positive-results-phase-3-0
WEBMar 20, 2023 · BOSTON--(BUSINESS WIRE)--Mar. 20, 2023-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced positive topline results from its Phase 3 EMERGENT-3 trial evaluating …
DA: 57 PA: 74 MOZ Rank: 81
-
Karuna Therapeutics Announces Positive Results from Phase 3 …
https://www.businesswire.com/news/home/20220808005222/en/Karuna-Therapeutics-Announces-Positive-Results-from-Phase-3-EMERGENT-2-Trial-of-KarXT-in-Schizophrenia
WEBAug 8, 2022 · BOSTON-- ( BUSINESS WIRE )--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with...
DA: 72 PA: 45 MOZ Rank: 94
-
Bristol Myers Squibb to buy Karuna Therapeutics - CNBC
https://www.cnbc.com/2023/12/22/bristol-myers-squibb-to-buy-karuna-therapeutics.html
WEBDec 22, 2023 · Karuna develops medications for patients living with neurological and psychiatric conditions. The company’s lead asset is an antipsychotic called KarXT, which is expected to serve as a treatment...
DA: 47 PA: 25 MOZ Rank: 34
-
Investor Relations • Karuna Therapeutics
https://investors.karunatx.com/
WEBKaruna is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Our team is uniquely steeped in neuroscience – with extensive expertise in the research, development and commercialization of CNS agents – and has profound, first-hand ...
DA: 88 PA: 94 MOZ Rank: 18
